Literature DB >> 32425396

Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma.

Emanuele Cencini1,2, Alberto Fabbri1,2, Adele Santoni1,2, Bianca Mecacci1,2, Monica Bocchia1,2.   

Abstract

An uncommon association between multiple myeloma and Hodgkin lymphoma (HL) was observed in some case reports, while an association with monoclonal gammopathy of uncertain significance (MGUS) is exceedingly rare. We have diagnosed 110 HL cases from 2008 to 2018; here we report 4 HL cases associated with MGUS. MGUS was diagnosed before HL (1 case), together with HL (1 case) or after HL (2 cases). M-component was IgG/k (3 cases) and IgG/k and IgG/λ (1 case), MGUS was not influenced by HL treatment (2 cases), raised after therapy (1 case), while in the last case MGUS appeared after ASCT while HL was in complete remission. We suggest to further study a possible link between MGUS and HL and to perform serum immunofixation if protein electrophoresis shows a suspected discrete band. The comprehension of pathophysiology of this association and a possible role of cytokines such as IL-6 and antilymphoma therapies such as nivolumab or ASCT to MGUS development could represent an interesting research field that requires further investigations. © Indian Society of Hematology and Blood Transfusion 2019.

Entities:  

Keywords:  Diagnosis; Hodgkin lymphoma; Interleukins; MGUS

Year:  2019        PMID: 32425396      PMCID: PMC7229058          DOI: 10.1007/s12288-019-01242-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

1.  Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.

Authors:  Enrico Tiacci; Erik Ladewig; Gianluca Schiavoni; Alex Penson; Elisabetta Fortini; Valentina Pettirossi; Yuchun Wang; Ariele Rosseto; Alessandra Venanzi; Sofija Vlasevska; Roberta Pacini; Simonetta Piattoni; Alessia Tabarrini; Alessandra Pucciarini; Barbara Bigerna; Alessia Santi; Alessandro M Gianni; Simonetta Viviani; Antonello Cabras; Stefano Ascani; Barbara Crescenzi; Cristina Mecucci; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  Blood       Date:  2018-04-12       Impact factor: 22.113

2.  Acquired red cell aplasia associated with monoclonal gammopathy of undetermined significance.

Authors:  Akaolisa S Eziokwu; Bernard Silver; Christy Samaras
Journal:  Leuk Lymphoma       Date:  2019-02-03

3.  The significance of serum immunoglobulin paraprotein in diffuse large B-cell lymphoma.

Authors:  M Christina Cox; Arianna Di Napoli; Alberto Fabbri; Emanuele Cencini; Luigi Ruco
Journal:  Br J Haematol       Date:  2017-08-17       Impact factor: 6.998

4.  Serum and urinary monoclonal immunoglobulins in Hodgkin's disease. Report of two cases.

Authors:  E Pascali; A Pezzoli
Journal:  Haematologica       Date:  1993 Nov-Dec       Impact factor: 9.941

5.  Prevalence of monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; Janice R Offord; Angela Dispenzieri; Jerry A Katzmann; L Joseph Melton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

6.  Concurrent diagnoses of Hodgkin lymphoma and biclonal myeloma in the bone marrow.

Authors:  Alison R Huppmann; Min-Ling Liu; Victor E Nava
Journal:  Ann Diagn Pathol       Date:  2009-12-01       Impact factor: 2.090

7.  Hodgkin's lymphoma associated with plasma cell neoplasia: cytological features and review of the literature.

Authors:  Bahram R Oliai; Maureen F Zakowski; Oscar Lin
Journal:  Diagn Cytopathol       Date:  2005-09       Impact factor: 1.582

8.  UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).

Authors:  Jenny Bird; Judith Behrens; Jan Westin; Ingemar Turesson; Mark Drayson; Robert Beetham; Shirley D'Sa; Richard Soutar; Anders Waage; Nina Gulbrandsen; Henrik Gregersen; Eric Low
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

Review 9.  Hodgkin lymphoma.

Authors:  Paolo G Gobbi; Andrés J M Ferreri; Maurilio Ponzoni; Alessandro Levis
Journal:  Crit Rev Oncol Hematol       Date:  2012-08-04       Impact factor: 6.312

10.  Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.

Authors:  Preethi Reddy Marri; Lucy S Hodge; Matthew J Maurer; Steven C Ziesmer; Susan L Slager; Thomas M Habermann; Brian K Link; James R Cerhan; Anne J Novak; Stephen M Ansell
Journal:  Clin Cancer Res       Date:  2013-10-18       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.